Network architecture predisposes an enzyme to pharmacologic or genetic targeting

844 [Article]
  • Research Highlight: Kostic M. (2016) Small Molecule Inhibitors versus Genetic Knockdown: Round One. Cell Chem Biol, 23, 313.